Anticoagulant
Anticoagulant is a pharmaceutical drug with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Anticoagulants for PFO Patients
Clinical Trials (8)
Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Anticoagulants for PFO Patients
Anticoagulant-associated Intracranial Hemorrhage
Carotid Web and Stroke Registry.
Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8